PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising improvements across many healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, much more reliable alternate for therapeutic use, particular